Skip to main content

Table 1 Characteristics at baseline, prior to chemotherapy initiation, of the Montreal patient cohort

From: Sperm DNA methylome abnormalities occur both pre- and post-treatment in men with Hodgkin disease and testicular cancer

Measure

CC

HD

TC

n

7

7

6

Age (years)

27.00 ± 2.29

25.00 ± 1.72

28.83 ± 1.14

Smokers

0

1

1

Sperm Conc. (millions/mL)

31.29 ± 5.16

91.29 ± 28.79

44.50 ± 10.46

Fast + Slow % Motility

48.29 ± 10.89

44.43 ± 1-.24

49.50 ± 8.99

Treatment

N/A

ABVD

Non-seminoma—BEP

  1. Mean ± SEM
  2. CC community control, HD Hodgkin disease, TC testicular cancer, N/A not applicable, ABVD doxorubicin, bleomycin, vinblastine, dacarbazine, BEP bleomycin, etoposide, cisplatin